Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Weifang Zhongshi Pharmaceutical is a specialized pharmaceutical manufacturer based in Weifang, Shandong Province, China, primarily serving the animal health and veterinary sectors. The company focuses on the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished veterinary drug formulations. Its core product portfolio includes a comprehensive range of sulfonamides, antibiotics, and antiparasitic agents, such as sulfamonomethoxine and diclazuril. Operating with Good Manufacturing Practice (GMP) certification, the company maintains a significant presence in both the domestic Chinese market and international export markets. Weifang Zhongshi Pharmaceutical is recognized for its integrated chemical synthesis capabilities and its role as a key supplier of essential medications for livestock and poultry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Weifang Zhongshi Pharmaceutical.